Atsushi Yoshimori

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Quality Control

Protein Protein

Convolutional Neural Network

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Medicines (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuhiro Abe, Mami Ozako, Miki Inukai, Yoe Matsuyuki, Shinnosuke Kitayama, Chisato Kanai, Chiaki Nagai, Chai C Gopalasingam, Christoph Gerle, Hideki Shigematsu, Nariyoshi Umekubo, Satoshi Yokoshima, Atsushi Yoshimori
Deep learning driven de novo drug design based on gastric proton pump structures. Communications biology 6 (1) (2023)
Atsushi Yoshimori, Jürgen Bajorath
Motif2Mol: Prediction of New Active Compounds Based on Sequence Motifs of Ligand Binding Sites in Proteins Using a Biochemical Language Model. Biomolecules 13 (5) (2023)
Kumiko Tsuihiji, Eiji Honda, Kanehisa Kojoh, Shizue Katoh, Tomonori Taguri, Atsushi Yoshimori, Hajime Takashima
Rational Strategy for Designing Peptidomimetic Small Molecules Based on Cyclic Peptides Targeting Protein-Protein Interaction between CTLA-4 and B7-1. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Kumiko Tsuihiji, Eiji Honda, Kanehisa Kojoh, Shizue Katoh, Tomonori Taguri, Atsushi Yoshimori, Hajime Takashima
Rational Strategy for Designing Peptidomimetic Small Molecules Based on Cyclic Peptides Targeting Protein-Protein Interaction between CTLA-4 and B7-1. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Kumiko Tsuihiji, Eiji Honda, Kanehisa Kojoh, Shizue Katoh, Tomonori Taguri, Atsushi Yoshimori, Hajime Takashima
Rational Strategy for Designing Peptidomimetic Small Molecules Based on Cyclic Peptides Targeting Protein-Protein Interaction between CTLA-4 and B7-1. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Kumiko Tsuihiji, Eiji Honda, Kanehisa Kojoh, Shizue Katoh, Tomonori Taguri, Atsushi Yoshimori, Hajime Takashima
Rational Strategy for Designing Peptidomimetic Small Molecules Based on Cyclic Peptides Targeting Protein-Protein Interaction between CTLA-4 and B7-1. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Atsushi Yoshimori, Filip Miljković, Jürgen Bajorath
Approach for the Design of Covalent Protein Kinase Inhibitors via Focused Deep Generative Modeling. Molecules (Basel, Switzerland) 27 (2) (2022)
Atsushi Yoshimori
Prediction of Molecular Properties Using Molecular Topographic Map. Molecules (Basel, Switzerland) 26 (15) (2021)
Chisato Kanai, Enzo Kawasaki, Ryuta Murakami, Yusuke Morita, Atsushi Yoshimori
Computational Prediction of Compound-Protein Interactions for Orphan Targets Using CGBVS. Molecules (Basel, Switzerland) 26 (17) (2021)
Atsushi Yoshimori, Enzo Kawasaki, Ryuta Murakami, Chisato Kanai
Discovery of Novel eEF2K Inhibitors Using HTS Fingerprint Generated from Predicted Profiling of Compound-Protein Interactions. Medicines (Basel, Switzerland) 8 (5) (2021)
Atsushi Yoshimori, Yasunobu Asawa, Enzo Kawasaki, Tomohiko Tasaka, Seiji Matsuda, Toru Sekikawa, Satoshi Tanabe, Masahiro Neya, Hideaki Natsugari, Chisato Kanai
Design and Synthesis of DDR1 Inhibitors with a Desired Pharmacophore Using Deep Generative Models. ChemMedChem 16 (6) (2021)